ES2164018A1 - Lithium salt based formulation of human syncytial respiratory virus medicine has the general formula ALi(n) where A is the salt anion and n equals the number of negative charges of the anion - Google Patents
Lithium salt based formulation of human syncytial respiratory virus medicine has the general formula ALi(n) where A is the salt anion and n equals the number of negative charges of the anionInfo
- Publication number
- ES2164018A1 ES2164018A1 ES200001347A ES200001347A ES2164018A1 ES 2164018 A1 ES2164018 A1 ES 2164018A1 ES 200001347 A ES200001347 A ES 200001347A ES 200001347 A ES200001347 A ES 200001347A ES 2164018 A1 ES2164018 A1 ES 2164018A1
- Authority
- ES
- Spain
- Prior art keywords
- anion
- equals
- general formula
- negative charges
- based formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Lithium salt based formulation of human syncytial respiratory virus medicine has the general formula ALi(n) where A is the salt anion and n equals the number of negative charges of the anion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200001347A ES2164018B1 (en) | 2000-05-26 | 2000-05-26 | USE OF A LITHIUM SALT IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF THE INFECTION CAUSED BY THE HUMAN SYNTHETIC RESPIRATORY VIRUS (VRDH) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200001347A ES2164018B1 (en) | 2000-05-26 | 2000-05-26 | USE OF A LITHIUM SALT IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF THE INFECTION CAUSED BY THE HUMAN SYNTHETIC RESPIRATORY VIRUS (VRDH) |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2164018A1 true ES2164018A1 (en) | 2002-02-01 |
ES2164018B1 ES2164018B1 (en) | 2003-06-16 |
Family
ID=8493689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200001347A Expired - Fee Related ES2164018B1 (en) | 2000-05-26 | 2000-05-26 | USE OF A LITHIUM SALT IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF THE INFECTION CAUSED BY THE HUMAN SYNTHETIC RESPIRATORY VIRUS (VRDH) |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2164018B1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135312A2 (en) * | 1983-07-27 | 1985-03-27 | Pharmaceuticals Limited Scotia | Anti-viral compositions |
ES2008767A6 (en) * | 1987-11-13 | 1989-08-01 | Medical Research Int | Destruction of intra-and extra-cellular micro-organisms |
EP0484112A2 (en) * | 1990-10-31 | 1992-05-06 | Scotia Holdings Plc | Use of lithium in the treatment or prophylaxis of Molluscum contagiosum |
ES2034326T3 (en) * | 1987-09-22 | 1993-04-01 | Atlantic Pharmaceutical Products Limited | EXPERT COMPOSITION. |
FR2715301A1 (en) * | 1994-01-24 | 1995-07-28 | Aromafarm Ltd | Antiviral use of zinc and lithium ascorbate(s) |
WO1998017288A1 (en) * | 1996-10-22 | 1998-04-30 | Scotia Holdings Plc | Lithium containing medicament for combatting papilloma virus infections |
EP0978289A1 (en) * | 1998-07-29 | 2000-02-09 | Aleksandr Ivanovic Iljin | Virucide drug containing iodine |
-
2000
- 2000-05-26 ES ES200001347A patent/ES2164018B1/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135312A2 (en) * | 1983-07-27 | 1985-03-27 | Pharmaceuticals Limited Scotia | Anti-viral compositions |
ES2034326T3 (en) * | 1987-09-22 | 1993-04-01 | Atlantic Pharmaceutical Products Limited | EXPERT COMPOSITION. |
ES2008767A6 (en) * | 1987-11-13 | 1989-08-01 | Medical Research Int | Destruction of intra-and extra-cellular micro-organisms |
EP0484112A2 (en) * | 1990-10-31 | 1992-05-06 | Scotia Holdings Plc | Use of lithium in the treatment or prophylaxis of Molluscum contagiosum |
FR2715301A1 (en) * | 1994-01-24 | 1995-07-28 | Aromafarm Ltd | Antiviral use of zinc and lithium ascorbate(s) |
WO1998017288A1 (en) * | 1996-10-22 | 1998-04-30 | Scotia Holdings Plc | Lithium containing medicament for combatting papilloma virus infections |
EP0978289A1 (en) * | 1998-07-29 | 2000-02-09 | Aleksandr Ivanovic Iljin | Virucide drug containing iodine |
Also Published As
Publication number | Publication date |
---|---|
ES2164018B1 (en) | 2003-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ515392A (en) | Respiratory syncytial virus replication inhibitors | |
YU57600A (en) | Bicyclic hydroxamic acid derivatives | |
MY127126A (en) | Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation | |
NO20065380L (en) | Use of R - (+) - 2- (3-diisopropylamino-1-phenylpropyl) -4-hydroxymethylphenylisosbutyric acid hydrogen fumarate for the preparation of a medicament for the treatment of urinary incontinence and other spasmogenic diseases. | |
MX9201621A (en) | USEFUL HETEROCICLIC AMINES IN THE THERAPY OF ASTHMA AND INFLAMMATION OF THE RESPIRATORY TRACT. | |
EA200101156A1 (en) | DRUG COMPOSITIONS OF A NEW TYPE ON THE BASIS OF POSSESSING HOLYNTHERGIC ACTION OF COMPOUNDS AND β-MIMETIC | |
DE69420412D1 (en) | THERAPEUTIC INHALATION PREPARATION | |
GB0105772D0 (en) | Use | |
NZ526088A (en) | Urea substituted imidazoquinoline ethers | |
MXPA04004601A (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments. | |
UA85708C2 (en) | Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases | |
GEP20084284B (en) | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | |
NZ298769A (en) | use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception | |
RS20070077A (en) | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflamatory diseases | |
JPS53118516A (en) | Inactivation disinfectant of hepatitis-b virus | |
NO982989L (en) | Use of inhibitors of the cellular Na + / H + exchanger (NHE) for the manufacture of a medicament for respiratory stimulation | |
ES8800161A1 (en) | Quinolyl glycinamide derivatives, process for their preparation and their pharmaceutical use as psychotropes. | |
GB9108629D0 (en) | Heterocyclic pharmaceutical compounds,preparation and use | |
ES2164018A1 (en) | Lithium salt based formulation of human syncytial respiratory virus medicine has the general formula ALi(n) where A is the salt anion and n equals the number of negative charges of the anion | |
EA200401303A1 (en) | MEDICINES CONTAINING STEROIDS AND NEW ANTICHOLINERGIC MEANS | |
EE200200088A (en) | Use of bis-sulfonamides in the manufacture of a medicament for the prevention or treatment of hyperlipidemia | |
TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
JPS5396388A (en) | Preparation of l-phenylalanine | |
AU2003281257A1 (en) | A novel use of rapamycin and structural analogues thereof | |
AU1039601A (en) | Medicaments for treatment of respiratory syncytial virus infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20020201 Kind code of ref document: A1 Effective date: 20020201 |
|
FG2A | Definitive protection |
Ref document number: 2164018B1 Country of ref document: ES |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180807 |